Article
Methotrexate Triglutamate as a Determinant of Clinical Response in Mexican Patients With Rheumatoid Arthritis: Pharmacokinetics and Dose Recommendation.
Journal of clinical pharmacology - 1 Aug 2021
Huerta-García Ana P, Rodríguez-Báez Ana S, Medellín-Garibay Susanna E, Portales-Pérez Diana P, Martínez-Martínez Marco U, Abud-Mendoza Carlos, Herrera-Van Oostdam David, Romano-Moreno Silvia, Milán-Segovia Rosa Del C
Abstract excerpt
Methotrexate is the gold standard treatment in rheumatoid arthritis. Once absorbed, it is internalized in cells, where glutamate residues are added to produce polyglutamated forms, which are responsible for the effect of methotrexate. The aim of the current study is to determine the relationship between methotrexate triglutamate concentrations and the clinical evolution in rheumatoid arthritis patients, as well...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
